Product Details
Product Details
Product Specification
| References | 1. Mingzhu Yang, et al., Chemical-induced chromatin remodeling reprograms mouse ESCs to totipotent-like stem cells. Cell Stem Cell 2022 Mar 3 Xin Guan, et al., Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis. Nature Communication. May 20, 2022 Qian-Yue Zhang, et al., Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto's thyroiditis. Nature Communications Feb 9, 2022 4. Dabbs David J. Diagnostic immunohistochemistry (M). Beijing: Peking University Medical Press, September 2008. Ed Harlow, David Lane. Technical guidelines for antibodies (M). Beijing: Science Press, 2002: 79-80, 105. Stack, E. C., et al., Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods, 2014 70 (1): 46-58. 7. Money helps the country. Jiao Lei. Application of multi-labeled immunofluorescence staining and Doppler imaging in histological studies. Chinese Journal of Histochemistry and Cytochemistry, 2017 (4): 373-382. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Usage |
I. Specimen requirements 1. Formalin-fixed paraffin blocks or slides, large tissue sections or TMAs; paraffin seal must be intact. 2. For slide specimens, tissue must adhere tightly to the slide without folds; slides must be free of cracks, scratches or stains. 3. Tissue must contain >1 000 cells. 4. Blocks must contain solid tumour tissue; necrotic tumour, fine-needle aspirates or cytospins will impair staining. 5. Tissue must be fixed in 10 % neutral-buffered formalin for 18–24 h. 6. Cut 4 µm sections on adhesive slides; prepare slides within one week after fixation. 7. Do NOT use any adhesives in the water-bath; place tissue on the front centre of the slide. Drain vertically on absorbent paper and gently tap off droplets—never wipe the slide. 8. Dry slides on a 45 °C hot plate for 30 min (air-dry ≥1 h if no hot plate is used). II. Assay procedure 1. Equipment required: pipettes, oven, microwave, IHC pen, antigen-retrieval vessel, staining jars, timer, humid incubation box, coverslips, fume hood, wash bottle, fluorescence microscope, 100 mL & 1 000 mL cylinders, etc. 2. Reagents required: sterile de-ionised water (abs9259), xylene, ethanol (100 %, 95 %, 70 %), 10 % neutral-buffered formalin, primary antibodies, blocking buffer, TBST, etc. 3. Reagent preparation 1) Fluorophore dilution: 100× stock dyes are diluted 1:100 in signal-amplification buffer (prepare fresh). DAPI 100× stock is diluted 1:100 in sterile water. 2) Secondary antibody: the kit supplies a mouse/rabbit universal secondary; verify species compatibility (goat host). 4. Imaging: fluorescence microscope or whole-slide scanner equipped with filter sets matching the excitation/emission spectra listed in the dye table. III. Paraffin-section protocol 1. Deparaffinisation & rehydration a) Fresh xylene 10 min ×3. b) Ethanol gradient: 100 % 5 min → 95 % 5 min → 70 % 2 min. c) Sterile water rinse 1 min ×3. d) Optional post-fixation: 10 % neutral formalin or 4 % PFA 10–30 min, water rinse 1 min ×3. e) Optional permeabilisation: permeabilisation reagent 15 min, PBST 3 min ×3. 2. Heat-induced epitope retrieval (HIER) a) Immerse slides in 1× antigen-retrieval buffer in microwave vessel. b) Microwave at high power until boiling. c) Maintain low power 15 min (top up liquid to prevent drying). d) Cool to room temperature (RT). 3. Quenching & blocking a) Remove excess buffer. b) Circle tissue with IHC pen; cover with 3 % H₂O₂ 10 min, PBST 3 min ×3. c) Block with blocking buffer 10–30 min at RT with shaking; discard. 4. Primary antibody incubation a) Remove blocking buffer. b) Add diluted primary antibody to cover tissue. c) Incubate 1 h at RT with shaking (optimise if necessary). d) 1×TBST 3 min ×2. 5. Secondary antibody incubation a) Remove wash buffer. b) Add HRP-conjugated secondary to cover tissue. c) Incubate 10 min at RT in humid box. d) 1×TBST 3 min ×2. 6. Fluorescent signal amplification a) Remove wash buffer. b) Add 100 µL 1× TSA fluorophore working solution (1:100 dilution) to cover tissue. c) Incubate 10 min at RT with shaking. d) 1×TBST 3 min ×3. e) Microwave retrieval; cool to RT. f) Sterile water rinse, then 1×TBST 2 min. 7. Next staining cycle (skip for single colour) a) Check staining under microscope; keep tissue wet with TBST. b) Block 10–30 min (no quenching needed). c) Repeat steps 4–6. d) After final cycle proceed to nuclear staining & mounting. 8. Nuclear staining & mounting Add 1×DAPI working solution 5 min at RT. 1×TBST 2 min ×3. Apply antifade mounting medium and coverslip; seal edges with clear nail polish for long-term storage. 9. Imaging & analysis: visualise on fluorescence microscope. IV. Fresh-frozen-section protocol (requires antibody-stripping buffer abs994) 1. Quenching, permeabilisation & blocking a) Equilibrate frozen slides to RT; PBST 3 min ×3. b) Optional fixation: 10 % neutral formalin or 4 % PFA 10–30 min, water rinse 1 min ×3. c) Optional permeabilisation: permeabilisation reagent 15 min, PBST 3 min ×3. d) Circle tissue; 3 % H₂O₂ 10 min, PBST 3 min ×3. e) Block 10–30 min; discard. 2. Primary antibody: same as paraffin step 4. 3. Secondary antibody: same as paraffin step 5. 4. TSA amplification a–d) identical to paraffin step 6a–d. e) Add antibody-stripping buffer (abs994) 15–20 min at 37 °C. f) Water rinse, then 1×TBST 2 min. 5. Next cycle (skip for single colour) a–d) same logic as paraffin step 7. 6. Nuclear staining & mounting: identical to paraffin step 8. 7. Imaging & analysis. V. Interpretation 1. Any change in retrieval, incubation time or temperature can produce erroneous results. 2. Each run must include a tissue-positive control and a reagent-negative control. 3. If the positive control fails, the entire batch is invalid. VI. Performance characteristics 1. Accuracy: positive control tissue must stain positively; negative control must remain unstained. 2. Within-batch reproducibility: triplicate sections stained with the same kit lot must yield identical patterns. VII. Spectral data
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Theory | Multiplex fluorescence immunohistochemical staining is based on the principle of specific binding of antigen and antibody. The secondary antibody labeled with horseradish peroxidase (HRP) is selected to activate the fluorescent dye in the kit and covalently bind the signal to the antigen. In situ multi-target staining of tissues or cells is achieved by multiple rounds of staining cycles with the aid of different fluorescent dye labels. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Synonym | Multicolor kit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Description | The tissue microenvironment harbors a complex cellular composition whose phenotype, state, abundance, and spatial distribution carry profound biological significance and clinical value. These characteristics can be visualized in situ by antibody-based staining. Immunohistochemistry (IHC) is a routine technique for interrogating tissue architecture and in-situ protein expression; however, conventional single-color IHC reveals only one marker at a time, making it insufficient to depict the intricate cellular constituents, states, and inter-cellular relationships within the microenvironment—information that is indispensable for disease diagnosis and therapy. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Composition |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| General Notes | 1. This kit is intended exclusively for immunohistochemistry; any other application is prohibited. 2. Operation must be performed only by qualified laboratory personnel. 3. Appropriate personal protective equipment must be worn to prevent contact with skin and eyes. 4. Reagents may lose activity after the stated expiry date; do not use beyond expiration. 5. Mixing any staining component of this kit with products from other manufacturers may lead to unpredictable staining artefacts. 6. Incomplete de-paraffinisation can compromise staining quality.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Storage Temp. | Fluorescent dyes should be stored in the dark from light at 2 ~ 8 ℃, and the validity period is 12 months from receipt of the goods. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Applications | It is mainly used for immunohistochemical staining of tissues, paraffin sections and TMA chips. It can also be used for frozen sections and cell crawling sections, and needs to be matched with abs994 antibody eluate (specific for mIHC). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Picture
Picture
Immunohistochemistry


